<p>How can T1D screening programs be effectively established in the clinic, and what are the considerations to get started? </p><p>Our host, <strong>Dr. Alice Cheng</strong>, explores this topic with <strong>James Stainer</strong>, a Registered Nurse and Certified Diabetes Educator at Windsor-Essex Community Health Centre.</p><p>Join our experts for a foundational discussion detailing the initiation of the <strong>first community-based T1D screening program in Canada </strong>at Windsor-Essex Community Health Care Centre. Learn about important considerations throughout the <strong>planning and screening process</strong> including strategies to <strong>garner awareness, share results, and facilitate continued monitoring</strong>. Hear about how the <strong>multidisciplinary screening team</strong> collaborates and is <strong>setting the stage for additional programs towards the proactive detection of T1D</strong>.</p><p><strong>Don’t miss the conversation!</strong> </p><p>The views and opinions expressed in this episode are those of the speakers, and do not necessarily reflect the views or positions of any entities they represent. </p><p><strong>Declaration of conflict of interest: </strong> </p><p><strong>Dr. Alice Cheng:</strong></p><p>· Direct financial relationship, including receipt of honoraria: Abbott, Amgen, Astellas, AstraZeneca, Bayer, Biomea Fusion, Boehringer Ingelheim, Dexcom, Eli Lilly, GSK, Insulet, HLS Therapeutics, Medtronic, MSD, Novo Nordisk, Pfizer, Sandoz, Sanofi, Vertex, CPD Network, Canadian Collaborative Research Network, Master Clinical Alliance, Canadian Medical &amp; Surgical Knowledge Translation Research Group, Sea Courses, Alliance of Best Practices in Health Education, Partners in Progressive Medical Education, MD Briefcase, LMC Physician Inc., Medscape, Humber River Health, Timed Right, The ACADEMY, International Atherosclerosis Society, Canadian Cardiovascular Society, Diabetes Canada, ADA. Membership on advisory boards or speaker’s bureaus: Abbott, Amgen, Astellas, AstraZeneca, Bayer, Biomea Fusion, Boehringer Ingelheim, Dexcom, Eli Lilly, GSK, Insulet, HLS Therapeutics, Medtronic, MSD, Novo Nordisk, Pfizer, Sandoz, Sanofi, Vertex. Funded grants, research, or clinical trials: Applied Therapeutics, Novo Nordisk, Sanofi.</p><p><strong>James Stainer:</strong></p><p>· Direct financial relationship, including receipt of honoraria: Sanofi, Dexcom, Abbott, Eli Lilly, Novo Nordisk, Janssen. Membership on advisory boards or speaker’s bureaus: Sanofi, Abbott, Eli Lilly. Funded grants, research, or clinical trials: AstraZeneca.</p><p>MAT-CA-2600205</p>